Alcresta Therapeutics Virtual Patent Marking

This page is intended to serve as notice under 35 U.S.C. § 287(a).

The following U.S. patents apply to Alcresta’s product RELiZORB^®:

U.S. Patent No. 9,668,942

U.S. Patent No. 9,687,420

U.S. Patent No. 9,775,783

U.S. Patent No. 9,775,784

U.S. Patent No. 10,258,590

US Patent No. 10,632,047

US Patent No. 10,828,239

US Patent No. 11,045,440

Other Patents Pending